Stat6	B-protein
is	O
necessary	O
and	O
sufficient	O
for	O
IL-4	O
's	O
role	O
in	O
Th2	O
differentiation	O
and	O
cell	O
expansion	O
.	O

IL-4	B-protein
plays	O
a	O
critical	O
role	O
in	O
the	O
differentiation	O
of	O
T	O
CR-stimulated	B-cell_type
naive	I-cell_type
CD4	I-cell_type
T	I-cell_type
cells	I-cell_type
to	O
the	O
Th2	O
phenotype	O
.	O

In	O
response	O
to	O
IL-4	B-protein
,	O
the	O
IL-4R	B-protein
activates	O
a	O
set	O
of	O
phosphotyrosine	B-protein
binding	I-protein
domain-containing	I-protein
proteins	I-protein
,	O
including	O
insulin	B-protein
receptor	I-protein
substrate	I-protein
1/2	I-protein
,	O
Shc	B-protein
,	O
and	O
IL-4R	B-protein
interacting	I-protein
protein	I-protein
,	O
as	O
well	O
as	O
Stat6	B-protein
.	O

Stat6	B-protein
has	O
been	O
shown	O
to	O
be	O
required	O
for	O
Th2	O
differentiation	O
.	O

To	O
determine	O
the	O
roles	O
of	O
the	O
phosphotyrosine	B-protein
binding	I-protein
adaptors	I-protein
in	O
Th2	O
differentiation	O
,	O
we	O
prepared	O
a	O
retrovirus	O
containing	O
a	O
mutant	O
of	O
the	O
human	B-protein
(	I-protein
h	I-protein
)	I-protein
IL-4R	I-protein
alpha-chain	I-protein
,	O
Y497F	B-protein
,	O
which	O
is	O
unable	O
to	O
recruit	O
these	O
adaptors	O
.	O

The	O
mutant	B-protein
hIL-4Ralpha	I-protein
,	O
as	O
well	O
as	O
the	O
wild-type	B-protein
(	I-protein
WT	I-protein
)	I-protein
hIL-4Ralpha	I-protein
,	O
was	O
introduced	O
into	O
naive	B-cell_type
CD4	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Upon	O
hIL-4	O
stimulation	O
,	O
Y497F	B-protein
worked	O
as	O
well	O
as	O
the	O
WT	B-protein
hIL-4Ralpha	I-protein
in	O
driving	O
Th2	O
differentiation	O
,	O
as	O
measured	O
by	O
Gata3	O
up-regulation	O
and	O
IL-4	O
production	O
.	O

Furthermore	O
,	O
IL-4-driven	O
cell	O
expansion	O
was	O
also	O
normal	O
in	O
the	O
cells	O
infected	O
with	O
Y497F	B-protein
,	O
although	O
cells	O
infected	O
with	O
Y497F	B-protein
were	O
not	O
capable	O
of	O
phosphorylating	O
insulin	B-protein
receptor	I-protein
substrate	I-protein
2	I-protein
.	O

These	O
results	O
suggest	O
that	O
the	O
signal	O
pathway	O
mediated	O
by	O
Y497	B-protein
is	O
dispensable	O
for	O
both	O
IL-4	B-protein
-driven	O
Th2	O
differentiation	O
and	O
cell	O
expansion	O
.	O

Both	O
WT	B-protein
and	I-protein
Y497F	I-protein
hIL-4Ralpha	I-protein
lose	O
the	O
ability	O
to	O
drive	O
Th2	O
differentiation	O
and	O
cell	O
expansion	O
in	O
Stat6-knockout	B-cell_type
CD4	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

A	O
constitutively	O
activated	O
form	O
of	O
Stat6	B-protein
introduced	O
into	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
resulted	O
in	O
both	O
Th2	O
differentiation	O
and	O
enhanced	O
cell	O
expansion	O
.	O

Thus	O
,	O
activated	B-protein
Stat6	I-protein
is	O
necessary	O
and	O
sufficient	O
to	O
mediate	O
both	O
IL-4	B-protein
-driven	O
Th2	O
differentiation	O
and	O
cell	O
expansion	O
in	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

``	NULL
m	NULL
B	NULL
o	NULL
_-	NULL
.	NULL

_	NULL
The	NULL
Attune	NULL
``	NULL
NXT	NULL
Flow	NULL
Cytometer	NULL
system	NULL
-	NULL
-	NULL
Let	NULL
's	NULL
get	NULL
to	NULL
the	NULL
science	NULL
e	NULL
#	NULL
#	NULL
invitrogen	NULL
Stato	NULL
Is	NULL
Necessary	NULL
and	NULL
Sufficient	NULL
for	NULL
IL-4	NULL
's	NULL
}	NULL
Role	NULL
in	NULL
Th2	NULL
Differentiation	NULL
and	NULL
Cell	NULL
Immunology	NULL
Expansion	NULL
AP	NULL
“	NULL
meJournal	NULL
o	NULL
\ge	NULL
?	NULL

u	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Jinfang	NULL
Zhu	NULL
,	NULL
Liying	NULL
Guo	NULL
,	NULL
Cynthia	NULL
J.	NULL
Watson	NULL
,	NULL
Jane	NULL
Hu-Li	NULL
and	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

William	NULL
E.	NULL
Paul	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:7276-7281	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.12.7276	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/12/7276	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
42	NULL
articles	NULL
,	NULL
20	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/12/7276.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Stat6	NULL
Is	NULL
Necessary	NULL
and	NULL
Sufficient	NULL
for	NULL
IL-4	NULL
's	NULL
Role	NULL
in	NULL
Th2	NULL
Differentiation	NULL
and	NULL
Cell	NULL
Expansion	NULL
Jinfang	NULL
Zhu	NULL
,	NULL
Liying	NULL
Guo	NULL
,	NULL
Cynthia	NULL
J.	NULL
Watson	NULL
,	NULL
Jane	NULL
Hu-Li	NULL
,	NULL
and	NULL
William	NULL
E.	NULL
Paul	NULL
IL-4	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
TCR-stimulated	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
to	NULL
the	NULL
Th2	NULL
phenotype	NULL
.	NULL

In	NULL
response	NULL
to	NULL
IL-4	NULL
,	NULL
the	NULL
IL-4R	NULL
activates	NULL
a	NULL
set	NULL
of	NULL
phosphotyrosine	NULL
binding	NULL
domain-containing	NULL
proteins	NULL
,	NULL
including	NULL
insulin	NULL
receptor	NULL
substrate	NULL
1/2	NULL
,	NULL
She	NULL
,	NULL
and	NULL
IL-4R	NULL
interacting	NULL
protein	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Stat6	NULL
.	NULL

Stat6	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
Th2	NULL
differentiation	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
phosphotyrosine	NULL
binding	NULL
adaptors	NULL
in	NULL
Th2	NULL
differentiation	NULL
,	NULL
we	NULL
prepared	NULL
a	NULL
retrovirus	NULL
containing	NULL
a	NULL
mutant	NULL
of	NULL
the	NULL
human	NULL
(	NULL
h	NULL
)	NULL
IL-4R	NULL
«	NULL
-chain	NULL
,	NULL
Y497F	NULL
,	NULL
which	NULL
is	NULL
unable	NULL
to	NULL
recruit	NULL
these	NULL
adaptors	NULL
.	NULL

The	NULL
mutant	NULL
hIL-4Ra	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
hIL-4Ra	NULL
,	NULL
was	NULL
introduced	NULL
into	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Upon	NULL
hIL-4	NULL
stimulation	NULL
,	NULL
Y497F	NULL
worked	NULL
as	NULL
well	NULL
as	NULL
the	NULL
WT	NULL
hIL-4Ra	NULL
in	NULL
driving	NULL
Th2	NULL
differentiation	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
Gata3	NULL
up-regulation	NULL
and	NULL
IL-4	NULL
production	NULL
.	NULL

Furthermore	NULL
,	NULL
IL-4-driven	NULL
cell	NULL
expansion	NULL
was	NULL
also	NULL
normal	NULL
in	NULL
the	NULL
cells	NULL
infected	NULL
with	NULL
Y497F	NULL
,	NULL
although	NULL
cells	NULL
infected	NULL
with	NULL
Y497F	NULL
were	NULL
not	NULL
capable	NULL
of	NULL
phosphorylating	NULL
insulin	NULL
receptor	NULL
substrate	NULL
2	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
signal	NULL
pathway	NULL
mediated	NULL
by	NULL
Y497	NULL
is	NULL
dispensable	NULL
for	NULL
both	NULL
IL-4-driven	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
.	NULL

Both	NULL
WT	NULL
and	NULL
Y497F	NULL
hIL-4Ra	NULL
lose	NULL
the	NULL
ability	NULL
to	NULL
drive	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
in	NULL
Stat6-knockout	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
constitutively	NULL
activated	NULL
form	NULL
of	NULL
Stat6	NULL
introduced	NULL
into	NULL
CD4	NULL
T	NULL
cells	NULL
resulted	NULL
in	NULL
both	NULL
Th2	NULL
differentiation	NULL
and	NULL
enhanced	NULL
cell	NULL
expansion	NULL
.	NULL

Thus	NULL
,	NULL
activated	NULL
Stat6	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
mediate	NULL
both	NULL
IL-4-driven	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
7276-7281.	NULL
hematopoietic	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
controls	NULL
Th2	NULL
polariza-	NULL
tion	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
costimulant	NULL
of	NULL
cell	NULL
growth	NULL
.	NULL

These	NULL
functions	NULL
of	NULL
IL-4	NULL
are	NULL
achieved	NULL
through	NULL
IL-4R-mediated	NULL
signal	NULL
transduction	NULL
followed	NULL
by	NULL
specific	NULL
gene	NULL
expression	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Upon	NULL
IL-4	NULL
stimulation	NULL
,	NULL
the	NULL
IL-4R	NULL
a-chain	NULL
(	NULL
3	NULL
)	NULL
and	NULL
the	NULL
IL-2R	NULL
y-chain	NULL
(	NULL
4	NULL
)	NULL
,	NULL
which	NULL
is	NULL
also	NULL
shared	NULL
by	NULL
cytokine	NULL
receptors	NULL
for	NULL
IL-2	NULL
,	NULL
IL-7	NULL
,	NULL
IL-9	NULL
,	NULL
and	NULL
IL-15	NULL
,	NULL
are	NULL
heterodimerized	NULL
.	NULL

The	NULL
nonreceptor	NULL
tyrosine	NULL
Janus	NULL
kinases	NULL
1	NULL
and	NULL
3	NULL
,	NULL
constitutively	NULL
associated	NULL
with	NULL
IL-4R	NULL
«	NULL
-chain	NULL
(	NULL
IL-4Ra	NULL
)	NULL
and	NULL
IL-2R	NULL
y-chain	NULL
,	NULL
respectively	NULL
(	NULL
5-7	NULL
)	NULL
,	NULL
become	NULL
activated	NULL
and	NULL
phosphorylate	NULL
some	NULL
or	NULL
all	NULL
of	NULL
the	NULL
conserved	NULL
tyrosines	NULL
of	NULL
IL-4Ra	NULL
.	NULL

These	NULL
phosphotyrosines	NULL
and	NULL
the	NULL
immediately	NULL
surrounding	NULL
amino	NULL
acids	NULL
within	NULL
IL-4Ra	NULL
provide	NULL
docking	NULL
sites	NULL
for	NULL
the	NULL
phosphotyrosine	NULL
binding-do-main	NULL
(	NULL
PTBD	NULL
)	NULL
*	NULL
proteins	NULL
insulin	NULL
receptor	NULL
substrate	NULL
(	NULL
IRS	NULL
)	NULL
1/2	NULL
(	NULL
8-10	NULL
)	NULL
,	NULL
Shc	NULL
(	NULL
11	NULL
)	NULL
,	NULL
IL-4R	NULL
interacting	NULL
protein	NULL
(	NULL
FRIP	NULL
)	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
dok	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
Stat6	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
human	NULL
(	NULL
L	NULL
)	NULL
IL-4Ra	NULL
,	NULL
the	NULL
PTBD	NULL
adapters	NULL
interact	NULL
with	NULL
the	NULL
first	NULL
conserved	NULL
tyrosine	NULL
(	NULL
Y497	NULL
)	NULL
,	NULL
and	NULL
Stat6	NULL
interacts	NULL
with	NULL
the	NULL
second	NULL
,	NULL
third	NULL
,	NULL
and	NULL
fourth	NULL
conserved	NULL
tyrosines	NULL
(	NULL
Y¥575	NULL
,	NULL
Y¥603	NULL
,	NULL
and	NULL
Y631	NULL
)	NULL
.	NULL

Two	NULL
major	NULL
IL-4	NULL
signaling	NULL
pathways	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
PTBD	NULL
proteins	NULL
and	NULL
Stat6	NULL
,	NULL
respectively	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

After	NULL
PTBD	NULL
proteins	NULL
bind	NULL
to	NULL
IL-4Ra	NULL
,	NULL
they	NULL
become	NULL
tyrosyl	NULL
phosphorylated	NULL
and	NULL
provide	NULL
further	NULL
docking	NULL
sites	NULL
for	NULL
other	NULL
downstream	NULL
molecules	NULL
such	NULL
as	NULL
p85	NULL
of	NULL
I	NULL
nterleukin-4	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
behavior	NULL
of	NULL
Laboratory	NULL
of	NULL
Immunology	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
1	NULL
,	NULL
2001	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
13	NULL
,	NULL
2001	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
William	NULL
E.	NULL
Paul	NULL
,	NULL
Laboratory	NULL
of	NULL
Immunology	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
10	NULL
Center	NULL
Drive	NULL
MSC	NULL
1892	NULL
,	NULL
Building	NULL
10	NULL
,	NULL
Room	NULL
11N311	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
wepaul	NULL
@	NULL
nih.gov	NULL
?	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PTBD	NULL
,	NULL
phosphotyrosine	NULL
binding	NULL
domain	NULL
;	NULL
IRS	NULL
,	NULL
insulin	NULL
receptor	NULL
substrate	NULL
;	NULL
FRIP	NULL
,	NULL
IL-4R	NULL
interacting	NULL
protein	NULL
;	NULL
h	NULL
,	NULL
human	NULL
;	NULL
PI-3K	NULL
,	NULL
phos-phatidylinositol	NULL
3-kinase	NULL
;	NULL
WT	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
RV	NULL
,	NULL
retrovirus	NULL
;	NULL
ThN	NULL
,	NULL
null	NULL
Th	NULL
cell	NULL
;	NULL
GFP	NULL
,	NULL
green	NULL
fluorescence	NULL
protein	NULL
;	NULL
GFP-RV	NULL
,	NULL
retroviral	NULL
vector	NULL
containing	NULL
an	NULL
internal	NULL
ribosomal	NULL
entry	NULL
sequence	NULL
and	NULL
humanized	NULL
GFP	NULL
cDNA	NULL
;	NULL
StatéVT	NULL
,	NULL
the	NULL
plasmid	NULL
peDNA3-StatéVT	NULL
containing	NULL
a	NULL
constitutively	NULL
activated	NULL
Stat6	NULL
.	NULL

Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
phosphatidylinositol-3-kinase	NULL
(	NULL
PI-3K	NULL
)	NULL
and	NULL
Grb2	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
PI-3K	NULL
and	NULL
,	NULL
in	NULL
some	NULL
instances	NULL
,	NULL
of	NULL
the	NULL
Ras/mitogen-ac-tivated	NULL
protein	NULL
kinase	NULL
cascades	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
the	NULL
promyeloid	NULL
cell	NULL
line	NULL
32D	NULL
,	NULL
transfection	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
IRS1	NULL
and	NULL
2	NULL
are	NULL
important	NULL
in	NULL
IL-4-mediated	NULL
cell	NULL
proliferation	NULL
and	NULL
resistance	NULL
to	NULL
apoptosis	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
was	NULL
mediated	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
PI-3K	NULL
.	NULL

Stat6	NULL
is	NULL
recruited	NULL
to	NULL
the	NULL
IL-4R	NULL
complex	NULL
by	NULL
binding	NULL
to	NULL
any	NULL
of	NULL
three	NULL
phosphotyrosines	NULL
in	NULL
IL-4Ra	NULL
.	NULL

It	NULL
becomes	NULL
tyrosyl	NULL
phosphorylated	NULL
at	NULL
its	NULL
C	NULL
terminus	NULL
through	NULL
the	NULL
action	NULL
of	NULL
Janus	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
1	NULL
and/or	NULL
3	NULL
.	NULL

Phosphorylated	NULL
Stat6	NULL
dimerizes	NULL
,	NULL
migrates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
binds	NULL
to	NULL
specific	NULL
DNA	NULL
elements	NULL
,	NULL
and	NULL
,	NULL
together	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
activates	NULL
transcription	NULL
of	NULL
some	NULL
IL-4-induced	NULL
genes	NULL
(	NULL
23-27	NULL
)	NULL
.	NULL

The	NULL
differentiation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
Th2	NULL
cells	NULL
requires	NULL
both	NULL
TCR-	NULL
and	NULL
IL-4-mediated	NULL
signals	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

IL-4	NULL
activation	NULL
of	NULL
Stat6	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
step	NULL
in	NULL
driving	NULL
Th2	NULL
differentiation	NULL
(	NULL
31-33	NULL
)	NULL
;	NULL
the	NULL
role	NULL
of	NULL
IRS2	NULL
and	NULL
other	NULL
PTBD	NULL
proteins	NULL
during	NULL
Th2	NULL
differentiation	NULL
is	NULL
unclear	NULL
.	NULL

To	NULL
examine	NULL
a	NULL
role	NULL
for	NULL
the	NULL
PTBD	NULL
proteins	NULL
in	NULL
IL-4-mediated	NULL
Th2	NULL
differentiation	NULL
and	NULL
IL-4-driven	NULL
proliferation	NULL
in	NULL
CD4	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
a	NULL
retrovirus	NULL
(	NULL
RV	NULL
)	NULL
system	NULL
to	NULL
introduce	NULL
h	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
mutant	NULL
IL-4Ra	NULL
into	NULL
€D4	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
was	NULL
found	NULL
that	NULL
Y497	NULL
,	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
PTBD	NULL
protein	NULL
,	NULL
is	NULL
dispensable	NULL
for	NULL
both	NULL
IL-4-driven	NULL
Th2	NULL
differentiation	NULL
and	NULL
for	NULL
cell	NULL
expansion	NULL
.	NULL

Using	NULL
Stat6-knockout	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Stat6	NULL
is	NULL
necessary	NULL
for	NULL
both	NULL
of	NULL
these	NULL
IL-4-induced	NULL
functions	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
using	NULL
a	NULL
RV	NULL
containing	NULL
constitutively	NULL
activated	NULL
Stat6	NULL
,	NULL
it	NULL
was	NULL
found	NULL
that	NULL
Stat6	NULL
is	NULL
not	NULL
only	NULL
necessary	NULL
but	NULL
also	NULL
sufficient	NULL
for	NULL
the	NULL
IL-4	NULL
effects	NULL
in	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Mice	NULL
and	NULL
cell	NULL
culture	NULL
Eight-	NULL
to	NULL
12-wk-old	NULL
BALB/c	NULL
mice	NULL
were	NULL
obtained	NULL
from	NULL
Frederick	NULL
Cancer	NULL
Research	NULL
Center	NULL
(	NULL
Frederick	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Statb	NULL
'~	NULL
BALB/c	NULL
mice	NULL
were	NULL
originally	NULL
obtained	NULL
from	NULL
Dr.	NULL
M.	NULL
Grusby	NULL
(	NULL
Harvard	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Naive	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
follows	NULL
:	NULL
Lymph	NULL
node	NULL
cells	NULL
were	NULL
depleted	NULL
of	NULL
CD8	NULL
*	NULL
cells	NULL
,	NULL
B220	NULL
*	NULL
cells	NULL
,	NULL
and	NULL
IA**	NULL
cells	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
FITC-labeled	NULL
anti-CD8	NULL
,	NULL
anti-B220	NULL
,	NULL
and	NULL
anti-IA	NULL
``	NULL
(	NULL
BD	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
plus	NULL
anti	NULL
0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
fluorescein-conjugated	NULL
magnetic	NULL
beads	NULL
(	NULL
PerSeptive	NULL
Diagnostics	NULL
,	NULL
Cam-bridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Purified	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
then	NULL
centrifuged	NULL
on	NULL
a	NULL
discontinuous	NULL
50	NULL
,	NULL
60	NULL
,	NULL
and	NULL
70	NULL
%	NULL
Percoll	NULL
gradient	NULL
.	NULL

Cells	NULL
with	NULL
a	NULL
density	NULL
of	NULL
>	NULL
60	NULL
%	NULL
were	NULL
collected	NULL
and	NULL
used	NULL
for	NULL
priming	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
was	NULL
usually	NULL
~98	NULL
%	NULL
.	NULL

CD44°*CD62	NULL
ligand	NULL
``	NULL
cells	NULL
constituted	NULL
~90	NULL
%	NULL
of	NULL
the	NULL
purified	NULL
CD4	NULL
cells	NULL
.	NULL

T	NULL
cell-depleted	NULL
APCs	NULL
were	NULL
prepared	NULL
by	NULL
incubating	NULL
spleen	NULL
cells	NULL
with	NULL
anti-Thy1.2	NULL
and	NULL
rabbit	NULL
complement	NULL
(	NULL
Cedarlane	NULL
Laboratories	NULL
,	NULL
Hornby	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
45	NULL
min	NULL
and	NULL
then	NULL
irradiated	NULL
at	NULL
3000	NULL
rad	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10°	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
cocultured	NULL
with	NULL
10	NULL
``	NULL
irradiated	NULL
T	NULL
cell-depleted	NULL
spleen	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD3	NULL
(	NULL
3	NULL
ug/ml	NULL
;	NULL
2C11	NULL
,	NULL
Harlan	NULL
Laboratories	NULL
,	NULL
Haslett	NULL
,	NULL
MJ	NULL
)	NULL
,	NULL
anti-CD28	NULL
(	NULL
3	NULL
pg/ml	NULL
;	NULL
Harlan	NULL
Laborato-ries	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
10	NULL
U/ml	NULL
)	NULL
,	NULL
and	NULL
different	NULL
combinations	NULL
of	NULL
Abs	NULL
and	NULL
cytokines	NULL
for	NULL
4	NULL
days	NULL
(	NULL
for	NULL
null	NULL
Th	NULL
cell	NULL
(	NULL
ThN	NULL
)	NULL
conditions	NULL
,	NULL
anti-IL-4	NULL
(	NULL
10	NULL
pg/m1	NULL
)	NULL
,	NULL
anti-IFN-y	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
,	NULL
and	NULL
anti-IL-12	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
;	NULL
for	NULL
Th1	NULL
conditions	NULL
,	NULL
anti-IL-4	NULL
(	NULL
11B11	NULL
;	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

plus	NULL
IL-12	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
;	NULL
for	NULL
Th2	NULL
conditions	NULL
,	NULL
IL-4	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
,	NULL
anti-IFN-y	NULL
(	NULL
10	NULL
pg/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
and	NULL
anti-IL-12	NULL
(	NULL
10	NULL
pg/m1	NULL
)	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
in	NULL
IL-2	NULL
for	NULL
3	NULL
additional	NULL
days	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
analyzed	NULL
by	NULL
intracellular	NULL
staining	NULL
for	NULL
IL-4	NULL
expression	NULL
or	NULL
further	NULL
primed	NULL
under	NULL
various	NULL
conditions	NULL
.	NULL

Preparation	NULL
of	NULL
retroviral	NULL
constructs	NULL
A	NULL
retroviral	NULL
vector	NULL
containing	NULL
an	NULL
internal	NULL
ribosomal	NULL
entry	NULL
sequence	NULL
and	NULL
humanized	NULL
green	NULL
fluorescence	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
cDNA	NULL
(	NULL
GFP-RV	NULL
)	NULL
,	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
K.	NULL
M.	NULL
Murphy	NULL
(	NULL
Washington	NULL
University	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
pcDNA3-Stat6VT	NULL
containing	NULL
a	NULL
constitutively	NULL
activated	NULL
Stat6	NULL
(	NULL
Stat6VT	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
U.	NULL
Schindler	NULL
(	NULL
Tularik	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
IL-4Ra	NULL
mutant	NULL
,	NULL
Y497F	NULL
,	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
XhoI	NULL
fragment	NULL
of	NULL
WT	NULL
or	NULL
mutant	NULL
IL-4R	NULL
«	NULL
was	NULL
cut	NULL
from	NULL
pEPS	NULL
vector	NULL
,	NULL
cloned	NULL
into	NULL
the	NULL
XhoI	NULL
site	NULL
of	NULL
GFP-RV	NULL
,	NULL
and	NULL
the	NULL
orientation	NULL
was	NULL
verified	NULL
.	NULL

The	NULL
StatéVT	NULL
was	NULL
cut	NULL
from	NULL
pcDNA3-StatéVT	NULL
by	NULL
partial	NULL
digestion	NULL
with	NULL
Xhol	NULL
and	NULL
BamHI	NULL
and	NULL
cloned	NULL
into	NULL
GFP-RV	NULL
between	NULL
the	NULL
Bg/lI	NULL
and	NULL
XhoI	NULL
sites	NULL
.	NULL

Preparation	NULL
of	NULL
RVs	NULL
and	NULL
infection	NULL
The	NULL
Phoenix-Eco	NULL
packaging	NULL
cell	NULL
line	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
G.	NULL
Nolan	NULL
,	NULL
Stanford	NULL
University	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
transfected	NULL
using	NULL
FuGENE	NULL
6	NULL
transfection	NULL
reagent	NULL
(	NULL
Roche	NULL
Diagnostic	NULL
Systems	NULL
,	NULL
Somerville	NULL
,	NULL
NJ	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Purified	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
activated	NULL
with	NULL
anti-CD3	NULL
and	NULL
APCs	NULL
under	NULL
ThN	NULL
conditions	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
medium	NULL
as	NULL
described	NULL
above	NULL
.	NULL

At	NULL
40	NULL
h	NULL
,	NULL
4	NULL
ml	NULL
of	NULL
supernatant	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
2	NULL
ml	NULL
of	NULL
virus-containing	NULL
supernatant	NULL
and	NULL
polybrene	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
at	NULL
5	NULL
ug/ml	NULL
was	NULL
added	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
centrifuged	NULL
at	NULL
2500	NULL
rpm	NULL
for	NULL
45	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
24	NULL
h	NULL
,	NULL
after	NULL
which	NULL
5	NULL
ml	NULL
of	NULL
fresh	NULL
ThN	NULL
medium	NULL
was	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
cultured	NULL
in	NULL
IL-2	NULL
(	NULL
10	NULL
U/ml	NULL
)	NULL
medium	NULL
3	NULL
days	NULL
later	NULL
for	NULL
3	NULL
additional	NULL
days	NULL
and	NULL
then	NULL
restimulated	NULL
under	NULL
various	NULL
conditions	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
GFP-positive	NULL
cells	NULL
were	NULL
sorted	NULL
after	NULL
restimulation	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
and	NULL
intracellular	NULL
staining	NULL
The	NULL
percentage	NULL
of	NULL
GFP-positive	NULL
cells	NULL
was	NULL
determined	NULL
at	NULL
various	NULL
times	NULL
after	NULL
infection	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
for	NULL
6	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
monensin	NULL
(	NULL
2	NULL
uM	NULL
)	NULL
during	NULL
last	NULL
4	NULL
h.	NULL
Harvested	NULL
samples	NULL
were	NULL
fixed	NULL
with	NULL
4	NULL
%	NULL
formaldehyde	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
permeabilized	NULL
in	NULL
0.5	NULL
%	NULL
saponin-1	NULL
%	NULL
BSA	NULL
in	NULL
PBS	NULL
before	NULL
staining	NULL
with	NULL
anti-IL-4-PE	NULL
or	NULL
anti-IL-4-APC	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
(	NULL
BD	NULL
Biosciences	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Semiquantitative	NULL
RT-PCR	NULL
After	NULL
infection	NULL
and	NULL
further	NULL
priming	NULL
,	NULL
CD4	NULL
T	NULL
cells	NULL
expressing	NULL
GFP	NULL
were	NULL
sorted	NULL
by	NULL
FACS	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
TRIzol	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
and	NULL
first	NULL
strand	NULL
cDNAs	NULL
were	NULL
made	NULL
using	NULL
the	NULL
SuperScript	NULL
preamplification	NULL
system	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Semiquantitative	NULL
PCR	NULL
was	NULL
conducted	NULL
in	NULL
a	NULL
GeneAmp	NULL
PCR	NULL
system	NULL
9700	NULL
(	NULL
Perkin-Elmer	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
using	NULL
Platinum	NULL
PCR	NULL
SuperMix	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
by	NULL
a	NULL
serial	NULL
dilution	NULL
of	NULL
the	NULL
cDNA	NULL
templates	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
Gata3	NULL
were	NULL
(	NULL
from	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
)	NULL
CTGACTATGAAGAAAGAAG	NULL
GCATCCAG	NULL
and	NULL
AAGTAGAAGGGGTCGGAGGAACTCT	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
B-actin	NULL
were	NULL
(	NULL
from	NULL
5	NULL
'	NULL
to	NULL
3	NULL
``	NULL
)	NULL
GATGACGATATCGCTGCGCTG	NULL
and	NULL
TACGACCAGAGGCATACAGG	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
Cytokine-treated	NULL
cells	NULL
(	NULL
10'/sample	NULL
)	NULL
were	NULL
harvested	NULL
and	NULL
lysed	NULL
with	NULL
1	NULL
ml	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
pyrophosphate	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
NaF	NULL
)	NULL
freshly	NULL
supplemented	NULL
with	NULL
inhibitors	NULL
(	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pepstatin	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
12,000	NULL
rpm	NULL
for	NULL
15	NULL
min	NULL
,	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
7277	NULL
2-3	NULL
ug	NULL
Ab	NULL
for	NULL
1	NULL
h	NULL
on	NULL
ice	NULL
and	NULL
precipitated	NULL
with	NULL
protein	NULL
G-agarose	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
at	NULL
4°C	NULL
overnight	NULL
on	NULL
a	NULL
rocker	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
eluted	NULL
with	NULL
2X	NULL
SDS-PAGE	NULL
loading	NULL
buffer	NULL
.	NULL

The	NULL
eluted	NULL
samples	NULL
were	NULL
separated	NULL
into	NULL
8	NULL
%	NULL
premade	NULL
acrylamide	NULL
gels	NULL
(	NULL
NOVEX	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
transferred	NULL
onto	NULL
Immobilon-P	NULL
membranes	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
probed	NULL
with	NULL
specific	NULL
Abs	NULL
followed	NULL
by	NULL
HRP-labeled	NULL
secondary	NULL
Abs	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
visualized	NULL
with	NULL
SuperSignal	NULL
West	NULL
Dura	NULL
Extended	NULL
Duration	NULL
Substrate	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
probed	NULL
membranes	NULL
were	NULL
stripped	NULL
with	NULL
stripping	NULL
buffer	NULL
(	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
62.5	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
2-ME	NULL
)	NULL
at	NULL
60°C	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
reprobed	NULL
with	NULL
a	NULL
second	NULL
Ab	NULL
.	NULL

Anti-Stat6é	NULL
was	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
;	NULL
anti-phosphorylated	NULL
tyrosine	NULL
(	NULL
4G10	NULL
)	NULL
and	NULL
anti-IRS2	NULL
were	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Results	NULL
Y497	NULL
is	NULL
dispensable	NULL
for	NULL
Th2	NULL
differentiation	NULL
Within	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
hIL-4R	NULL
-chain	NULL
(	NULL
hIL-4Ra	NULL
)	NULL
,	NULL
Y497	NULL
recruits	NULL
PTBD-containing	NULL
adaptors	NULL
,	NULL
such	NULL
as	NULL
IRS1/2	NULL
(	NULL
20	NULL
)	NULL
,	NULL
Shc	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
FRIP	NULL
(	NULL
12	NULL
)	NULL
,	NULL
when	NULL
it	NULL
is	NULL
phosphorylated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
IL-4	NULL
stimulation	NULL
.	NULL

The	NULL
Y497F	NULL
mutant	NULL
of	NULL
IL-4Ra	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
unable	NULL
to	NULL
mediate	NULL
phosphorylation	NULL
of	NULL
IRS1/2	NULL
,	NULL
Shc	NULL
,	NULL
and	NULL
FRIP	NULL
but	NULL
was	NULL
still	NULL
capable	NULL
of	NULL
activating	NULL
Stat6	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
used	NULL
this	NULL
mutant	NULL
to	NULL
study	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
PTBD-containing	NULL
adaptors	NULL
in	NULL
Th2	NULL
differentiation	NULL
.	NULL

BALB/c	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
and	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
with	NULL
anti-€CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
IL-2	NULL
,	NULL
anti-IL-4	NULL
,	NULL
anti-IFN-y	NULL
,	NULL
and	NULL
anti-IL-12	NULL
(	NULL
ThN	NULL
conditions	NULL
)	NULL
for	NULL
40	NULL
h.	NULL
The	NULL
activated	NULL
cells	NULL
were	NULL
then	NULL
infected	NULL
with	NULL
RVs	NULL
containing	NULL
either	NULL
WT	NULL
hIL-4Ra	NULL
or	NULL
Y497F	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
under	NULL
ThN	NULL
conditions	NULL
for	NULL
3	NULL
additional	NULL
days	NULL
and	NULL
then	NULL
washed	NULL
and	NULL
placed	NULL
in	NULL
IL-2	NULL
medium	NULL
for	NULL
3	NULL
days	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
GFP-positive	NULL
cells	NULL
was	NULL
checked	NULL
by	NULL
FACS	NULL
.	NULL

The	NULL
infected	NULL
cells	NULL
were	NULL
then	NULL
split	NULL
into	NULL
three	NULL
populations	NULL
and	NULL
further	NULL
primed	NULL
under	NULL
ThN	NULL
,	NULL
Th2	NULL
,	NULL
or	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

conditions	NULL
for	NULL
4	NULL
days	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
IL-4-producing	NULL
cells	NULL
was	NULL
measured	NULL
by	NULL
intracellular	NULL
staining	NULL
after	NULL
an	NULL
additional	NULL
3-day	NULL
culture	NULL
in	NULL
IL-2	NULL
.	NULL

Under	NULL
the	NULL
ThN	NULL
conditions	NULL
,	NULL
the	NULL
GFP-positive	NULL
and	NULL
GFP-negative	NULL
cells	NULL
from	NULL
each	NULL
of	NULL
the	NULL
infected	NULL
groups	NULL
made	NULL
little	NULL
IL-4	NULL
(	NULL
1.1-4.9	NULL
%	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Under	NULL
Th2	NULL
conditions	NULL
,	NULL
the	NULL
GFP-positive	NULL
and	NULL
GFP-negative	NULL
cells	NULL
from	NULL
each	NULL
of	NULL
the	NULL
infected	NULL
groups	NULL
developed	NULL
IL-4-producing	NULL
capacity	NULL
to	NULL
a	NULL
similar	NULL
degree	NULL
and	NULL
had	NULL
indistinguishable	NULL
percentages	NULL
of	NULL
IL-4	NULL
producers	NULL
(	NULL
13.6	NULL
vs	NULL
14.2	NULL
%	NULL
,	NULL
14.3	NULL
vs	NULL
14.5	NULL
%	NULL
,	NULL
and	NULL
19.4	NULL
vs	NULL
18.8	NULL
%	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
condition	NULL
,	NULL
23.8	NULL
%	NULL
of	NULL
the	NULL
GFP-positive	NULL
cells	NULL
expressing	NULL
WT	NULL
hIL-4Ra	NULL
were	NULL
capable	NULL
of	NULL
making	NULL
IL-4	NULL
,	NULL
whereas	NULL
only	NULL
2.9	NULL
%	NULL
of	NULL
GFP-negative	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
culture	NULL
could	NULL
produce	NULL
IL-4	NULL
.	NULL

Interestingly	NULL
,	NULL
23.7	NULL
%	NULL
of	NULL
the	NULL
GFP	NULL
cells	NULL
from	NULL
the	NULL
group	NULL
infected	NULL
with	NULL
theY497F	NULL
RV	NULL
could	NULL
produce	NULL
IL-4	NULL
,	NULL
a	NULL
percentage	NULL
that	NULL
was	NULL
essentially	NULL
the	NULL
same	NULL
as	NULL
those	NULL
that	NULL
had	NULL
been	NULL
infected	NULL
with	NULL
the	NULL
WT	NULL
receptor	NULL
RV	NULL
.	NULL

GFP-positive	NULL
cells	NULL
from	NULL
the	NULL
group	NULL
infected	NULL
with	NULL
empty	NULL
vector	NULL
developed	NULL
very	NULL
few	NULL
(	NULL
1.9	NULL
%	NULL
)	NULL
IL-4	NULL
producers	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
Y497	NULL
is	NULL
not	NULL
required	NULL
for	NULL
IL-4	NULL
stimulation	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
to	NULL
become	NULL
IL-4	NULL
producers	NULL
.	NULL

Because	NULL
Gata3	NULL
is	NULL
a	NULL
key	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
Th2	NULL
differentiation	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
infection	NULL
with	NULL
a	NULL
Gata3	NULL
RV	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
replace	NULL
the	NULL
need	NULL
for	NULL
IL-4	NULL
in	NULL
Th2	NULL
differentiation	NULL
(	NULL
37	NULL
)	NULL
,	NULL
we	NULL
checked	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
Gata3	NULL
in	NULL
our	NULL
primed	NULL
cells	NULL
.	NULL

The	NULL
GFP-positive	NULL
cells	NULL
from	NULL
the	NULL
groups	NULL
infected	NULL
with	NULL
either	NULL
WT	NULL
or	NULL
Y497F	NULL
RVs	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
under	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
conditions	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
Gata3	NULL
,	NULL
measured	NULL
by	NULL
RT-PCR	NULL
,	NULL
were	NULL
the	NULL
same	NULL
in	NULL
the	NULL
groups	NULL
expressing	NULL
the	NULL
WT	NULL
and	NULL
the	NULL
Y497F	NULL
hIL-4R	NULL
«	NULL
-chain	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

They	NULL
were	NULL
similar	NULL
to	NULL
expression	NULL
levels	NULL
in	NULL
conventionally	NULL
primed	NULL
Th2	NULL
cells	NULL
and	NULL
~10-fold	NULL
higher	NULL
than	NULL
expression	NULL
levels	NULL
in	NULL
conventionally	NULL
primed	NULL
ThN	NULL
cells	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
7278	NULL
has	NULL
:	NULL
ThN	NULL
Th2	NULL
ThN+hIL-4	NULL
Primin	NULL
con	NULL
ditigm	NULL
s	NULL
--	NULL
--	NULL
--	NULL
%	NULL
IL-4	NULL
producing	NULL
cells	NULL
--	NULL
--	NULL
-_	NULL
14	NULL
%	NULL
-	NULL
4.9	NULL
%	NULL
,	NULL
14.2	NULL
%	NULL
13.6	NULL
%	NULL
a	NULL
2.9	NULL
%	NULL
23.8	NULL
%	NULL
mi	NULL
02	NULL
0.48	NULL
mi	NULL
2.79	NULL
hIL-4Rc	NULL
_	NULL
P5	NULL
$	NULL
®	NULL
``	NULL
s	NULL
~s	NULL
``	NULL
s	NULL
[	NULL
as	NULL
!	NULL

ag	NULL
.	NULL

19	NULL
``	NULL
not	NULL
0	NULL
``	NULL
id	NULL
ad	NULL
)	NULL
as	NULL
no	NULL
``	NULL
no	NULL
``	NULL
10	NULL
d	NULL
as	NULL
n	NULL
ms	NULL
FLbH	NULL
FL1H	NULL
FL1-H	NULL
11	NULL
%	NULL
©21	NULL
%	NULL
14.5	NULL
%	NULL
14.3	NULL
%	NULL
1.9	NULL
%	NULL
23.7	NULL
%	NULL
}	NULL
12.76	NULL
1.71	NULL
Y497F	NULL
'	NULL
|	NULL
(	NULL
F	NULL
ioe	NULL
10°	NULL
ao	NULL
!	NULL

10	NULL
``	NULL
10°	NULL
as	NULL
``	NULL
0°	NULL
ao	NULL
ig	NULL
``	NULL
10	NULL
%	NULL
to	NULL
'	NULL
FL1H	NULL
FL1H	NULL
14	NULL
18°	NULL
wrlug	NULL
‘	NULL
wgm	NULL
“	NULL
>	NULL
¥	NULL
0	NULL
ao	NULL
)	NULL
aet	NULL
ao	NULL
ast	NULL
FLLH	NULL
2.0	NULL
%	NULL
21	NULL
%	NULL
142	NULL
18.8	NULL
%	NULL
19.4	NULL
%	NULL
1.9	NULL
%	NULL
1.9	NULL
%	NULL
142	NULL
0.10	NULL
51103104	NULL
10°	NULL
vector	NULL
Le	NULL
10	NULL
ue	NULL
10	NULL
10°	NULL
113r	NULL
10	NULL
%	NULL
of	NULL
IL-4	NULL
ait	NULL
,	NULL
FL1-H	NULL
GFP	NULL
FIGURE	NULL
1	NULL
.	NULL

Y497	NULL
is	NULL
dispensable	NULL
for	NULL
IL-4-mediated	NULL
development	NULL
of	NULL
IL-4-producing	NULL
capacity	NULL
.	NULL

BALB/c	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
and	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
with	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
IL-2	NULL
,	NULL
anti-IL-4	NULL
,	NULL
anti-IFN-	NULL
,	NULL
and	NULL
anti-IL-12	NULL
(	NULL
ThN	NULL
conditions	NULL
)	NULL
for	NULL
40	NULL
h.	NULL
The	NULL
activated	NULL
cells	NULL
were	NULL
then	NULL
infected	NULL
with	NULL
RVs	NULL
containing	NULL
either	NULL
WT	NULL
hIL-4Ra	NULL
or	NULL
Y497F	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
under	NULL
ThN	NULL
conditions	NULL
for	NULL
3	NULL
additional	NULL
days	NULL
and	NULL
then	NULL
washed	NULL
and	NULL
placed	NULL
in	NULL
IL-2	NULL
medium	NULL
for	NULL
3	NULL
days	NULL
.	NULL

The	NULL
infected	NULL
cells	NULL
were	NULL
then	NULL
split	NULL
into	NULL
three	NULL
populations	NULL
and	NULL
further	NULL
primed	NULL
under	NULL
ThN	NULL
,	NULL
Th2	NULL
,	NULL
or	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

conditions	NULL
for	NULL
4	NULL
days	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
GFP*	NULL
and	NULL
GFP~	NULL
IL-4-producing	NULL
CD4	NULL
cells	NULL
was	NULL
measured	NULL
by	NULL
intracellular	NULL
staining	NULL
after	NULL
3	NULL
additional	NULL
days	NULL
of	NULL
culture	NULL
in	NULL
IL-2	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
support	NULL
the	NULL
conclusions	NULL
that	NULL
Y497	NULL
of	NULL
hIL-4Ra	NULL
is	NULL
dispensable	NULL
for	NULL
IL-4-mediated	NULL
Th2	NULL
differentiation	NULL
.	NULL

Y497	NULL
is	NULL
dispensable	NULL
for	NULL
IL-4-mediated	NULL
cell	NULL
expansion	NULL
Cells	NULL
being	NULL
primed	NULL
under	NULL
Th2	NULL
conditions	NULL
expand	NULL
to	NULL
a	NULL
greater	NULL
degree	NULL
than	NULL
those	NULL
stimulated	NULL
under	NULL
ThN	NULL
or	NULL
Th1	NULL
conditions	NULL
,	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
IL-4	NULL
to	NULL
cultures	NULL
of	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
and	NULL
IL-2	NULL
markedly	NULL
enhances	NULL
cell	NULL
yield	NULL
(	NULL
38	NULL
)	NULL
.	NULL

By	NULL
infecting	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
with	NULL
hIL-4Ra	NULL
RV	NULL
,	NULL
we	NULL
could	NULL
compare	NULL
the	NULL
relative	NULL
IL-4-mediated	NULL
expansion	NULL
of	NULL
GFP-positive	NULL
and	NULL
GFP	NULL
-negative	NULL
cells	NULL
.	NULL

Relative	NULL
GFP	NULL
*/GFP_-	NULL
expansion	NULL
was	NULL
defined	NULL
as	NULL
(	NULL
percentage	NULL
of	NULL
GFP	NULL
*	NULL
cells	NULL
after	NULL
priming	NULL
)	NULL
X	NULL
(	NULL
percentage	NULL
of	NULL
GFP_	NULL
cells	NULL
after	NULL
infection	NULL
)	NULL
/	NULL
(	NULL
percentage	NULL
of	NULL
GFP	NULL
*	NULL
cells	NULL
after	NULL
infection	NULL
)	NULL
/	NULL
(	NULL
percentage	NULL
of	NULL
GFP_	NULL
cells	NULL
after	NULL
priming	NULL
)	NULL
.	NULL

Under	NULL
Th2	NULL
priming	NULL
conditions	NULL
,	NULL
both	NULL
GFP	NULL
*	NULL
and	NULL
GFP_	NULL
cells	NULL
from	NULL
the	NULL
groups	NULL
infected	NULL
with	NULL
any	NULL
of	NULL
the	NULL
vectors	NULL
expanded	NULL
equally	NULL
,	NULL
resulting	NULL
in	NULL
relative	NULL
expansions	NULL
of	NULL
1.1-1.3	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
would	NULL
be	NULL
anticipated	NULL
because	NULL
all	NULL
the	NULL
cells	NULL
can	NULL
respond	NULL
to	NULL
the	NULL
mouse	NULL
IL-4	NULL
that	NULL
is	NULL
present	NULL
.	NULL

Under	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
or	NULL
Th1	NULL
plus	NULL
hIL-4	NULL
conditions	NULL
,	NULL
the	NULL
GFP	NULL
*	NULL
cells	NULL
from	NULL
the	NULL
culture	NULL
infected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
lacking	NULL
hIL-4R	NULL
could	NULL
not	NULL
respond	NULL
to	NULL
hIL-4	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
GFP	NULL
*	NULL
cells	NULL
remained	NULL
the	NULL
same	NULL
after	NULL
priming	NULL
.	NULL

However	NULL
,	NULL
under	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
or	NULL
Th1	NULL
plus	NULL
hIL-4	NULL
conditions	NULL
,	NULL
the	NULL
GFP*	NULL
cells	NULL
from	NULL
the	NULL
culture	NULL
infected	NULL
with	NULL
WT	NULL
hIL-4Ra	NULL
grew	NULL
much	NULL
better	NULL
than	NULL
the	NULL
GFP_	NULL
cells	NULL
in	NULL
the	NULL
same	NULL
culture	NULL
.	NULL

The	NULL
relative	NULL
expansions	NULL
were	NULL
4.0	NULL
and	NULL
4.7	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
experiment	NULL
1	NULL
and	NULL
4.2	NULL
and	NULL
4.5	NULL
in	NULL
experiment	NULL
2	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
cells	NULL
infected	NULL
with	NULL
Y497F	NULL
hIL-4Ra	NULL
mutant	NULL
.	NULL

The	NULL
relative	NULL
expansion	NULL
in	NULL
the	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
and	NULL
the	NULL
Th1	NULL
plus	NULL
hIL-4	NULL
stimulated	NULL
cells	NULL
were	NULL
3.9	NULL
and	NULL
5.7	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
experiment	NULL
1	NULL
and	NULL
4.5	NULL
and	NULL
5.0	NULL
in	NULL
experiment	NULL
2	NULL
.	NULL

Thus	NULL
,	NULL
Y497	NULL
was	NULL
Stat6	NULL
IS	NULL
SUFFICIENT	NULL
FOR	NULL
IL-4	NULL
FUNCTION	NULL
IN	NULL
T	NULL
CELLS	NULL
ThN+hIL-4	NULL
hIL-4Ro	NULL
Y497F	NULL
Unsorted	NULL
Unsorted	NULL
ThN	NULL
Tha	NULL
722	NULL
?	NULL

10	NULL
3	NULL
10.3041	NULL
10	NULL
3	NULL
1	NULL
0.304	NULL
10	NULL
3	NULL
10.304	NULL
10	NULL
3	NULL
1	NULL
0.3	NULL
04	NULL
B-actin	NULL
FIGURE	NULL
2	NULL
.	NULL

Y497	NULL
is	NULL
dispensable	NULL
for	NULL
IL-4-mediated	NULL
induction	NULL
of	NULL
Gata3	NULL
expression	NULL
.	NULL

The	NULL
GFP*	NULL
cells	NULL
that	NULL
developed	NULL
as	NULL
a	NULL
result	NULL
of	NULL
ThN	NULL
plus	NULL
hIL-4-priming	NULL
of	NULL
cells	NULL
from	NULL
the	NULL
groups	NULL
infected	NULL
with	NULL
either	NULL
WT	NULL
or	NULL
Y497F	NULL
RVs	NULL
(	NULL
as	NULL
shown	NULL
in	NULL
the	NULL
right	NULL
panels	NULL
of	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
Gata3	NULL
and	NULL
B-actin	NULL
were	NULL
measured	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
.	NULL

Conventionally	NULL
primed	NULL
ThN	NULL
and	NULL
Th2	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
and	NULL
positive	NULL
controls	NULL
.	NULL

not	NULL
only	NULL
dispensable	NULL
for	NULL
Th2	NULL
differentiation	NULL
,	NULL
it	NULL
was	NULL
also	NULL
not	NULL
essential	NULL
for	NULL
IL-4-induced	NULL
T	NULL
cell	NULL
expansion	NULL
.	NULL

Y497	NULL
is	NULL
important	NULL
for	NULL
IRS2	NULL
phosphorylation	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
IRS2	NULL
phosphorylation	NULL
can	NULL
be	NULL
dramatically	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
either	NULL
naive	NULL
or	NULL
activated	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IL-4-induced	NULL
IRS1/2	NULL
phosphorylation	NULL
was	NULL
greatly	NULL
diminished	NULL
in	NULL
the	NULL
promyeloid	NULL
cell	NULL
line	NULL
32D-IRS1	NULL
transfected	NULL
with	NULL
Y497F	NULL
compared	NULL
with	NULL
those	NULL
transfected	NULL
with	NULL
WT	NULL
IL-4Ra	NULL
(	NULL
20	NULL
)	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
that	NULL
is	NULL
also	NULL
the	NULL
case	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

GFP	NULL
*	NULL
cells	NULL
were	NULL
purified	NULL
,	NULL
by	NULL
cell	NULL
sorting	NULL
,	NULL
from	NULL
CD4	NULL
T	NULL
cell	NULL
populations	NULL
infected	NULL
with	NULL
either	NULL
WT	NULL
IL-4Ra	NULL
RV	NULL
or	NULL
the	NULL
Y497F	NULL
RV	NULL
.	NULL

To	NULL
obtain	NULL
sufficient	NULL
cells	NULL
for	NULL
analysis	NULL
and	NULL
to	NULL
increase	NULL
expression	NULL
of	NULL
IRS2	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
sorted	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
two	NULL
further	NULL
rounds	NULL
of	NULL
priming	NULL
under	NULL
Th2	NULL
conditions	NULL
.	NULL

Upon	NULL
mouse	NULL
IL-4	NULL
stimulation	NULL
,	NULL
IRS2	NULL
and	NULL
Stat6	NULL
were	NULL
well	NULL
phosphorylated	NULL
in	NULL
both	NULL
cell	NULL
populations	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
cells	NULL
expressing	NULL
WT	NULL
hIL-4Ra	NULL
«	NULL
,	NULL
IRS2	NULL
and	NULL
Stat6	NULL
became	NULL
phosphorylated	NULL
upon	NULL
hIL-4	NULL
stimulation	NULL
.	NULL

However	NULL
,	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
Y497F	NULL
mutant	NULL
,	NULL
although	NULL
Stat6	NULL
phosphorylation	NULL
remained	NULL
normal	NULL
,	NULL
IRS2	NULL
phosphorylation	NULL
was	NULL
greatly	NULL
diminished	NULL
in	NULL
response	NULL
to	NULL
hIL-4	NULL
.	NULL

Because	NULL
cells	NULL
expressing	NULL
the	NULL
mutant	NULL
hIL-4R	NULL
a-chain	NULL
,	NULL
Y497F	NULL
,	NULL
showed	NULL
normal	NULL
IL-4-mediated	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
IRS2	NULL
appears	NULL
not	NULL
Relative	NULL
cell	NULL
expansion	NULL
|___	NULL
M	NULL
after	NULL
infection	NULL
U	NULL
1	NULL
round	NULL
2	NULL
rounds	NULL
[	NULL
~-B	NULL
1	NULL
round	NULL
,	NULL
exp2	NULL
GFP+/GFpP-	NULL
g	NULL
.g	NULL
C	NULL
ad	NULL
S	NULL
CJS	NULL
GZ	NULL
/	NULL
ThN+hIL-4	NULL
-	NULL
Thi+hlL-4	NULL
-	NULL
Th2+hIL-4	NULL
FIGURE	NULL
3	NULL
.	NULL

Y497	NULL
is	NULL
dispensable	NULL
for	NULL
IL-4-mediated	NULL
CD4	NULL
T	NULL
cell	NULL
expansion	NULL
.	NULL

BALB/c	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
and	NULL
infected	NULL
with	NULL
RVs	NULL
containing	NULL
either	NULL
WT	NULL
hIL-4Ra	NULL
or	NULL
Y497F	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
infected	NULL
cells	NULL
were	NULL
then	NULL
split	NULL
into	NULL
three	NULL
populations	NULL
and	NULL
further	NULL
primed	NULL
under	NULL
ThN	NULL
,	NULL
Th1	NULL
,	NULL
and	NULL
Th2	NULL
conditions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hIL-4	NULL
for	NULL
an	NULL
additional	NULL
one	NULL
or	NULL
two	NULL
rounds	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
GFP*	NULL
cells	NULL
was	NULL
checked	NULL
by	NULL
FACS	NULL
after	NULL
priming	NULL
and	NULL
a	NULL
3-day	NULL
culture	NULL
in	NULL
IL-2	NULL
.	NULL

The	NULL
relative	NULL
GFP*/GFP_~	NULL
expansion	NULL
was	NULL
defined	NULL
as	NULL
(	NULL
percentage	NULL
of	NULL
GFP	NULL
*	NULL
cells	NULL
after	NULL
priming	NULL
)	NULL
X	NULL
(	NULL
percentage	NULL
of	NULL
GFP~	NULL
cells	NULL
after	NULL
infection	NULL
)	NULL
/	NULL
(	NULL
percentage	NULL
of	NULL
GFP	NULL
*	NULL
cells	NULL
after	NULL
infection	NULL
)	NULL
/	NULL
(	NULL
percentage	NULL
of	NULL
GFP_	NULL
cells	NULL
after	NULL
priming	NULL
)	NULL
.	NULL

The	NULL
results	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
for	NULL
one	NULL
round	NULL
of	NULL
priming	NULL
and	NULL
one	NULL
experiment	NULL
for	NULL
two	NULL
rounds	NULL
of	NULL
priming	NULL
are	NULL
shown	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
mIL-4	NULL
=	NULL
-	NULL
+0	NULL
-	NULL
-	NULL
+	NULL
hIL4	NULL
=	NULL
>	NULL
-	NULL
>	NULL
40	NULL
-	NULL
~	NULL
o+	NULL
oIRS2	NULL
wee	NULL
ie	NULL
|_	NULL
with	NULL
-	NULL
1G10	NULL
oIRS2	NULL
‘	NULL
q-ﬁb	NULL
Win	NULL
wie	NULL
-	NULL
oIRS2	NULL
aStat6	NULL
_	NULL
@	NULL
name	NULL
1010	NULL
OStat6	NULL
-	NULL
uue	NULL
que	NULL
ene	NULL
ammeme	NULL
emt	NULL
.	NULL

oStatG	NULL
IP	NULL
hIL-4Ro	NULL
Y4A97F	NULL
IB	NULL
FIGURE	NULL
4	NULL
.	NULL

Y497	NULL
is	NULL
important	NULL
for	NULL
IL-4-mediated	NULL
IRS2	NULL
phosphorylation	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

GFP*	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
from	NULL
populations	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
infected	NULL
with	NULL
either	NULL
the	NULL
WT	NULL
IL-4R	NULL
«	NULL
or	NULL
the	NULL
Y497F	NULL
mutant	NULL
RV	NULL
.	NULL

They	NULL
were	NULL
further	NULL
primed	NULL
under	NULL
Th2	NULL
conditions	NULL
for	NULL
two	NULL
additional	NULL
rounds	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
,	NULL
cultured	NULL
in	NULL
serum-free	NULL
medium	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
mouse	NULL
IL-4	NULL
,	NULL
hIL-4	NULL
,	NULL
or	NULL
nothing	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
either	NULL
anti-IRS2	NULL
or	NULL
anti-Stat6	NULL
.	NULL

SDS-PAGE	NULL
was	NULL
performed	NULL
and	NULL
immunobotting	NULL
with	NULL
anti-phosphorylated	NULL
tyrosine	NULL
(	NULL
4G10	NULL
)	NULL
or	NULL
anti-IRS2	NULL
was	NULL
conducted	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Stat6	NULL
.	NULL

to	NULL
be	NULL
required	NULL
for	NULL
mediating	NULL
either	NULL
of	NULL
these	NULL
two	NULL
IL-4	NULL
functions	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Stat6	NULL
is	NULL
required	NULL
for	NULL
both	NULL
IL-4-driven	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
Stat6	NULL
is	NULL
crucial	NULL
for	NULL
Th2	NULL
differentiation	NULL
(	NULL
31-33	NULL
)	NULL
,	NULL
but	NULL
its	NULL
function	NULL
in	NULL
IL-4-driven	NULL
T	NULL
cell	NULL
proliferation	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

We	NULL
infected	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
Stat6-knockout	NULL
mice	NULL
with	NULL
the	NULL
hIL-4Ra	NULL
,	NULL
the	NULL
Y497F	NULL
,	NULL
and	NULL
``	NULL
empty	NULL
``	NULL
RVs	NULL
and	NULL
measured	NULL
relative	NULL
expansion	NULL
.	NULL

Under	NULL
ThN	NULL
conditions	NULL
with	NULL
added	NULL
hIL-4	NULL
,	NULL
the	NULL
relative	NULL
expansions	NULL
were	NULL
0.9-1.3	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiments	NULL
,	NULL
the	NULL
relative	NULL
expansions	NULL
taken	NULL
from	NULL
BALB/c	NULL
cells	NULL
infected	NULL
with	NULL
hIL-4Ra	NULL
were	NULL
4.4	NULL
and	NULL
3.8	NULL
.	NULL

The	NULL
Stat6	NULL
'~	NULL
cells	NULL
also	NULL
underwent	NULL
little	NULL
or	NULL
no	NULL
differentiation	NULL
to	NULL
IL-4-producing	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Stat6	NULL
is	NULL
required	NULL
for	NULL
both	NULL
IL-4-driven	NULL
Th2	NULL
differentiation	NULL
and	NULL
for	NULL
CD4	NULL
T	NULL
cell	NULL
expansion	NULL
.	NULL

Stat6	NULL
activation	NULL
is	NULL
sufficient	NULL
for	NULL
anti-CD3-stimulated	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
Recently	NULL
,	NULL
a	NULL
constitutively	NULL
active	NULL
Stat6	NULL
mutant	NULL
(	NULL
Stat6VT	NULL
)	NULL
has	NULL
been	NULL
derived	NULL
(	NULL
35	NULL
)	NULL
.	NULL

We	NULL
used	NULL
this	NULL
mutant	NULL
to	NULL
test	NULL
whether	NULL
Stat6	NULL
activation	NULL
is	NULL
sufficient	NULL
in	NULL
combination	NULL
with	NULL
anti-CD3/anti-CD28	NULL
to	NULL
drive	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
.	NULL

After	NULL
cloning	NULL
this	NULL
mutant	NULL
into	NULL
our	NULL
retroviral	NULL
vector	NULL
,	NULL
we	NULL
infected	NULL
anti-CD3/anti-CD28-activated	NULL
T	NULL
cells	NULL
with	NULL
WT	NULL
hIL-4Ra	NULL
RV	NULL
,	NULL
Stat6VT	NULL
RV	NULL
,	NULL
or	NULL
empty	NULL
vector	NULL
RV	NULL
.	NULL

Relative	NULL
cell	NULL
expansion	NULL
®	NULL
after	NULL
infection	NULL
O	NULL
ThN+hIL-4	NULL
,	NULL
exp1	NULL
~~	NULL
|_Z	NULL
ThNhIL-4	NULL
,	NULL
exp2	NULL
_________|	NULL
GFP+/GFP-	NULL
WT	NULL
Y497F	NULL
-	NULL
vector	NULL
WT	NULL
Staté-/-	NULL
BALB/c	NULL
FIGURE	NULL
5	NULL
.	NULL

Stat6	NULL
is	NULL
required	NULL
for	NULL
IL-4-mediated	NULL
CD4	NULL
T	NULL
cell	NULL
expansion	NULL
.	NULL

Stat6	NULL
'~	NULL
or	NULL
BALB/c	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
and	NULL
infected	NULL
with	NULL
RVs	NULL
containing	NULL
either	NULL
WT	NULL
hIL-4Ra	NULL
or	NULL
Y497F	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
infected	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
for	NULL
4	NULL
additional	NULL
days	NULL
under	NULL
ThN	NULL
conditions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hIL-4	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
GFP	NULL
*	NULL
cells	NULL
was	NULL
measured	NULL
by	NULL
FACS	NULL
after	NULL
3	NULL
days	NULL
of	NULL
culture	NULL
in	NULL
IL-2	NULL
.	NULL

The	NULL
results	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

7279	NULL
After	NULL
infection	NULL
,	NULL
the	NULL
cells	NULL
infected	NULL
with	NULL
IL-4Ra	NULL
«	NULL
RV	NULL
were	NULL
primed	NULL
under	NULL
ThN	NULL
conditions	NULL
with	NULL
hIL-4	NULL
;	NULL
cells	NULL
infected	NULL
with	NULL
empty	NULL
vector	NULL
RV	NULL
and	NULL
StatéVT	NULL
RV	NULL
were	NULL
primed	NULL
under	NULL
ThN	NULL
conditions	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hIL-4	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
,	NULL
the	NULL
GFP-	NULL
and	NULL
GFP	NULL
*	NULL
cells	NULL
infected	NULL
with	NULL
empty	NULL
vector	NULL
RV	NULL
made	NULL
little	NULL
IL-4	NULL
(	NULL
0.9	NULL
and	NULL
0.4	NULL
%	NULL
and	NULL
0.2	NULL
and	NULL
0.2	NULL
%	NULL
)	NULL
.	NULL

The	NULL
GFP-	NULL
and	NULL
GFP	NULL
*	NULL
cells	NULL
from	NULL
cultures	NULL
infected	NULL
with	NULL
hIL-4Ra	NULL
RV	NULL
had	NULL
very	NULL
different	NULL
percentages	NULL
of	NULL
IL-4-producing	NULL
cells	NULL
(	NULL
1.4	NULL
vs	NULL
11.4	NULL
%	NULL
and	NULL
0.6	NULL
vs	NULL
24.5	NULL
%	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
infected	NULL
with	NULL
Stat6VT	NULL
RV	NULL
and	NULL
primed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-4	NULL
showed	NULL
a	NULL
similar	NULL
pattern	NULL
.	NULL

In	NULL
the	NULL
two	NULL
experiments	NULL
presented	NULL
,	NULL
1.4	NULL
and	NULL
0.1	NULL
%	NULL
of	NULL
the	NULL
GFP_	NULL
cells	NULL
produced	NULL
IL-4	NULL
compared	NULL
with	NULL
16.2	NULL
and	NULL
28.7	NULL
%	NULL
of	NULL
the	NULL
GFP	NULL
*	NULL
cells	NULL
.	NULL

All	NULL
the	NULL
cells	NULL
cultured	NULL
under	NULL
Th2	NULL
conditions	NULL
with	NULL
mouse	NULL
IL-4	NULL
developed	NULL
a	NULL
substantial	NULL
proportion	NULL
of	NULL
IL-4-producing	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
cells	NULL
expressing	NULL
Stat6VT	NULL
showed	NULL
an	NULL
IL-4-independent	NULL
relative	NULL
expansion	NULL
similar	NULL
to	NULL
the	NULL
IL-4-dependent	NULL
relative	NULL
expansion	NULL
of	NULL
those	NULL
expressing	NULL
hIL-4Ra	NULL
(	NULL
5.5-	NULL
and	NULL
4.1-fold	NULL
,	NULL
respec-tively	NULL
;	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
a	NULL
second	NULL
experiment	NULL
in	NULL
which	NULL
we	NULL
observed	NULL
5.1-	NULL
and	NULL
4.4-fold	NULL
relative	NULL
expansion	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
Stat6	NULL
is	NULL
not	NULL
only	NULL
necessary	NULL
but	NULL
also	NULL
sufficient	NULL
to	NULL
drive	NULL
IL-4-mediated	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
in	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Discussion	NULL
Prior	NULL
transfection	NULL
studies	NULL
in	NULL
the	NULL
promyeloid	NULL
cell	NULL
line	NULL
32D	NULL
indicated	NULL
a	NULL
major	NULL
role	NULL
for	NULL
the	NULL
first	NULL
conserved	NULL
tyrosine	NULL
in	NULL
the	NULL
cytosolic	NULL
domain	NULL
of	NULL
the	NULL
IL-4R	NULL
a-chain	NULL
(	NULL
Y497	NULL
)	NULL
in	NULL
IL-4-mediated	NULL
cell	NULL
proliferation	NULL
and	NULL
survival	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

This	NULL
tyrosine	NULL
is	NULL
in	NULL
a	NULL
docking	NULL
site	NULL
for	NULL
PTBD	NULL
proteins	NULL
;	NULL
32D	NULL
cells	NULL
lack	NULL
IRS1	NULL
and	NULL
IRS2	NULL
,	NULL
two	NULL
of	NULL
the	NULL
major	NULL
PTBD	NULL
proteins	NULL
that	NULL
normally	NULL
interact	NULL
with	NULL
the	NULL
Y497	NULL
site	NULL
.	NULL

Mouse	NULL
IL-4	NULL
fails	NULL
to	NULL
stimulate	NULL
the	NULL
growth	NULL
of	NULL
WT	NULL
32D	NULL
cells	NULL
but	NULL
does	NULL
stimulate	NULL
the	NULL
growth	NULL
of	NULL
such	NULL
cells	NULL
transfected	NULL
with	NULL
cDNAs	NULL
for	NULL
IRS1	NULL
or	NULL
IRS2	NULL
.	NULL

Moreover	NULL
,	NULL
most	NULL
32D-IRS1	NULL
cell	NULL
lines	NULL
expressing	NULL
the	NULL
hIL-4Ra	NULL
mutant	NULL
Y497F	NULL
fail	NULL
to	NULL
grow	NULL
in	NULL
response	NULL
to	NULL
hIL-4	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
concluded	NULL
that	NULL
in	NULL
this	NULL
promeyloid	NULL
cell	NULL
line	NULL
,	NULL
PTBD	NULL
proteins	NULL
docking	NULL
to	NULL
phosphorylated	NULL
Y497	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
cell	NULL
growth	NULL
and	NULL
resistance	NULL
to	NULL
apoptosis	NULL
.	NULL

The	NULL
applicability	NULL
of	NULL
these	NULL
findings	NULL
to	NULL
normal	NULL
cells	NULL
and	NULL
to	NULL
naive	NULL
T	NULL
cells	NULL
in	NULL
particular	NULL
was	NULL
uncertain	NULL
.	NULL

Priming	NULL
conditions	NULL
ThN	NULL
ThN+hIL-4	NULL
ThN	NULL
--	NULL
--	NULL
--	NULL
%	NULL
IL-4	NULL
producing	NULL
cells	NULL
--	NULL
--	NULL
-A	NULL
,	NULL
0.9	NULL
%	NULL
-	NULL
0.4	NULL
%	NULL
1.4	NULL
%	NULL
11.4	NULL
%	NULL
14	NULL
%	NULL
-	NULL
16.2	NULL
%	NULL
®	NULL
«	NULL
Z	NULL
``	NULL
aot	NULL
ao	NULL
ao	NULL
``	NULL
aot	NULL
ao	NULL
``	NULL
L1H	NULL
0.6	NULL
%	NULL
-	NULL
24.5	NULL
%	NULL
0.1	NULL
%	NULL
-	NULL
28.7	NULL
%	NULL
3410310	NULL
“	NULL
L2	NULL
10	NULL
10°	NULL
wr	NULL
4	NULL
a	NULL
hIL-4Ra	NULL
Vector	NULL
Staté-VT	NULL
FIGURE	NULL
6	NULL
.	NULL

Stat6	NULL
activation	NULL
is	NULL
sufficient	NULL
for	NULL
anti-CD3-stimulated	NULL
Th2	NULL
differentiation	NULL
.	NULL

BALB/c	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
and	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
and	NULL
infected	NULL
with	NULL
RVs	NULL
containing	NULL
either	NULL
WT	NULL
hIL-4Ra	NULL
or	NULL
Stat6-VT	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
infected	NULL
cells	NULL
were	NULL
then	NULL
further	NULL
primed	NULL
under	NULL
ThN	NULL
conditions	NULL
(	NULL
vector	NULL
and	NULL
Stat6-VT	NULL
groups	NULL
)	NULL
or	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
conditions	NULL
(	NULL
hIL-4Ra	NULL
group	NULL
)	NULL
for	NULL
4	NULL
days	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
IL-4	NULL
producers	NULL
was	NULL
measured	NULL
by	NULL
intracellular	NULL
staining	NULL
after	NULL
3	NULL
additional	NULL
days	NULL
of	NULL
culture	NULL
in	NULL
IL-2	NULL
.	NULL

The	NULL
results	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
7280	NULL
Relative	NULL
cell	NULL
expansion	NULL
&	NULL
{	NULL
Z	NULL
ThN+hIL-4	NULL
,	NULL
exp1	NULL
--	NULL
-	NULL
H	NULL
ThN+hIL-4	NULL
,	NULL
exp2	NULL
U	NULL
ThN	NULL
,	NULL
exp1	NULL
§	NULL
ThN	NULL
,	NULL
exp2	NULL
--	NULL
-	NULL
|	NULL
4	NULL
|	NULL
3	NULL
GFP+/GFP-	NULL
Vector	NULL
-	NULL
hIL-4Ro	NULL
-	NULL
Staté-VT	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
Stat6	NULL
activation	NULL
is	NULL
sufficient	NULL
for	NULL
IL-4-driven	NULL
CD4	NULL
T	NULL
cell	NULL
expansion	NULL
.	NULL

BALB/c	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
and	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
and	NULL
infected	NULL
with	NULL
RVs	NULL
containing	NULL
either	NULL
WT	NULL
hIL-4Ra	NULL
or	NULL
Stat6é-VT	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
infected	NULL
cells	NULL
were	NULL
then	NULL
further	NULL
primed	NULL
under	NULL
ThN	NULL
conditions	NULL
(	NULL
vector	NULL
and	NULL
Stat6-VT	NULL
groups	NULL
)	NULL
or	NULL
ThN	NULL
plus	NULL
hIL-4	NULL
conditions	NULL
(	NULL
hIL-4Ra	NULL
group	NULL
)	NULL
for	NULL
4	NULL
days	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
GFP*	NULL
cells	NULL
was	NULL
measured	NULL
by	NULL
FACS	NULL
after	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
of	NULL
culture	NULL
in	NULL
IL-2	NULL
medium	NULL
.	NULL

The	NULL
results	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
two	NULL
signals	NULL
mediated	NULL
by	NULL
TCR	NULL
and	NULL
IL-4R	NULL
leads	NULL
to	NULL
Th2	NULL
differentiation	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
Th2	NULL
differentiation	NULL
can	NULL
occur	NULL
independently	NULL
of	NULL
IL-4-IL-4R-Stat6	NULL
in	NULL
vivo	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
even	NULL
in	NULL
in	NULL
vitro	NULL
culture	NULL
,	NULL
a	NULL
small	NULL
portion	NULL
of	NULL
cells	NULL
may	NULL
undergo	NULL
Th2	NULL
differentiation	NULL
independently	NULL
of	NULL
the	NULL
IL-4-IL-4R-Stat6	NULL
pathway	NULL
(	NULL
37	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
any	NULL
set	NULL
of	NULL
signals	NULL
that	NULL
leads	NULL
to	NULL
Gata3	NULL
expression	NULL
results	NULL
in	NULL
Th2	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
from	NULL
studies	NULL
using	NULL
cells	NULL
from	NULL
Staté-deficient	NULL
mice	NULL
that	NULL
Stat6	NULL
plays	NULL
a	NULL
dominant	NULL
role	NULL
in	NULL
IL-4-mediated	NULL
Th2	NULL
differentiation	NULL
(	NULL
31-33	NULL
)	NULL
and	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
expansion	NULL
over	NULL
a	NULL
3-	NULL
to	NULL
5-day	NULL
period	NULL
that	NULL
occurred	NULL
under	NULL
Th2	NULL
culture	NULL
conditions	NULL
.	NULL

Stat6	NULL
interacts	NULL
with	NULL
the	NULL
second	NULL
,	NULL
third	NULL
,	NULL
and	NULL
fourth	NULL
conserved	NULL
tyrosines	NULL
(	NULL
Y575	NULL
,	NULL
Y¥603	NULL
,	NULL
and	NULL
Y631	NULL
)	NULL
of	NULL
IL-4Ra	NULL
(	NULL
2	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
PTBD	NULL
adapters	NULL
that	NULL
interact	NULL
with	NULL
Y497	NULL
in	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
IL-4	NULL
was	NULL
uncertain	NULL
.	NULL

Here	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
Stat6	NULL
appears	NULL
to	NULL
be	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
mediate	NULL
the	NULL
IL-4	NULL
component	NULL
of	NULL
Th2	NULL
differentiation	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
T	NULL
cells	NULL
expressing	NULL
a	NULL
mutant	NULL
hIL-4R	NULL
«	NULL
-chain	NULL
(	NULL
Y497F	NULL
)	NULL
that	NULL
can	NULL
not	NULL
interact	NULL
with	NULL
PTBDs	NULL
are	NULL
nonetheless	NULL
fully	NULL
competent	NULL
to	NULL
differentiate	NULL
into	NULL
IL-4-producing	NULL
cells	NULL
under	NULL
the	NULL
influence	NULL
of	NULL
hIL-4	NULL
establishes	NULL
this	NULL
point	NULL
.	NULL

What	NULL
was	NULL
more	NULL
surprising	NULL
was	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
PTBD	NULL
proteins	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
expansion	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
stimulated	NULL
under	NULL
Th2-inducing	NULL
conditions	NULL
.	NULL

CD4	NULL
T	NULL
cells	NULL
expressing	NULL
the	NULL
Y497F	NULL
mutant	NULL
hIL-4R	NULL
«	NULL
-chain	NULL
were	NULL
as	NULL
competent	NULL
as	NULL
those	NULL
expressing	NULL
WT	NULL
receptors	NULL
in	NULL
such	NULL
expansion	NULL
.	NULL

Not	NULL
only	NULL
were	NULL
the	NULL
PTBD	NULL
proteins	NULL
not	NULL
important	NULL
in	NULL
this	NULL
expansion	NULL
or	NULL
in	NULL
Th2	NULL
differentiation	NULL
,	NULL
Stat6	NULL
was	NULL
required	NULL
for	NULL
both	NULL
.	NULL

CD4	NULL
T	NULL
cells	NULL
from	NULL
Stat6-deficient	NULL
mice	NULL
failed	NULL
to	NULL
polarize	NULL
to	NULL
IL-4	NULL
production	NULL
or	NULL
to	NULL
show	NULL
IL-4-dependent	NULL
expansion	NULL
when	NULL
cultured	NULL
under	NULL
Th2	NULL
conditions	NULL
.	NULL

Arai	NULL
and	NULL
colleagues	NULL
had	NULL
previously	NULL
infected	NULL
CD4	NULL
cells	NULL
stimulated	NULL
under	NULL
Thl	NULL
conditions	NULL
with	NULL
a	NULL
RV	NULL
containing	NULL
a	NULL
cDNA	NULL
for	NULL
a	NULL
Stat6-estrogen	NULL
receptor	NULL
fusion	NULL
protein	NULL
.	NULL

Dimerizing	NULL
the	NULL
fusion	NULL
protein	NULL
with	NULL
the	NULL
estrogen	NULL
analog	NULL
4-hydroxytamoxifen	NULL
activated	NULL
Stat6	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
Th2	NULL
cytokines	NULL
in	NULL
the	NULL
developing	NULL
cells	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
their	NULL
uptake	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Our	NULL
experiments	NULL
using	NULL
StatéVT	NULL
(	NULL
35	NULL
)	NULL
,	NULL
a	NULL
constitutively	NULL
active	NULL
Stat-6	NULL
mutant	NULL
,	NULL
showed	NULL
that	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-4	NULL
were	NULL
equivalent	NULL
to	NULL
the	NULL
IL-4-driven	NULL
differentiation	NULL
and	NULL
expansion	NULL
of	NULL
cells	NULL
expressing	NULL
the	NULL
WT	NULL
hIL-4Ra	NULL
«	NULL
.	NULL

Thus	NULL
,	NULL
activated	NULL
Stat6	NULL
appears	NULL
to	NULL
be	NULL
fully	NULL
responsible	NULL
for	NULL
mediating	NULL
the	NULL
IL-4-induced	NULL
Th2	NULL
polarization	NULL
and	NULL
cell	NULL
expansion	NULL
.	NULL

The	NULL
failure	NULL
to	NULL
observe	NULL
any	NULL
difference	NULL
in	NULL
the	NULL
behavior	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
expressing	NULL
the	NULL
WT	NULL
or	NULL
the	NULL
Y497F	NULL
mutant	NULL
hIL-4R	NULL
«	NULL
-chains	NULL
is	NULL
Stat6	NULL
IS	NULL
SUFFICIENT	NULL
FOR	NULL
IL-4	NULL
FUNCTION	NULL
IN	NULL
T	NULL
CELLS	NULL
not	NULL
likely	NULL
to	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
over-expression	NULL
of	NULL
the	NULL
hIL-4R	NULL
in	NULL
such	NULL
cells	NULL
.	NULL

Immunoblotting	NULL
studies	NULL
failed	NULL
to	NULL
show	NULL
more	NULL
receptors	NULL
on	NULL
these	NULL
cells	NULL
than	NULL
on	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
saw	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
relative	NULL
induction	NULL
of	NULL
IL-4-producing	NULL
cells	NULL
among	NULL
those	NULL
that	NULL
expressed	NULL
large	NULL
amounts	NULL
of	NULL
GFP	NULL
and	NULL
those	NULL
that	NULL
expressed	NULL
small	NULL
amounts	NULL
of	NULL
GFP	NULL
.	NULL

Because	NULL
relative	NULL
GFP	NULL
expression	NULL
levels	NULL
should	NULL
correlate	NULL
with	NULL
relative	NULL
IL-4R	NULL
expression	NULL
levels	NULL
using	NULL
a	NULL
RV	NULL
containing	NULL
both	NULL
cDNAs	NULL
,	NULL
there	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
a	NULL
correlation	NULL
between	NULL
the	NULL
number	NULL
of	NULL
expressed	NULL
receptors	NULL
and	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
response	NULL
.	NULL

The	NULL
role	NULL
that	NULL
PTBD	NULL
proteins	NULL
such	NULL
as	NULL
IRS2	NULL
play	NULL
in	NULL
T	NULL
cell	NULL
responses	NULL
needs	NULL
to	NULL
be	NULL
further	NULL
clarified	NULL
.	NULL

We	NULL
did	NULL
show	NULL
that	NULL
cells	NULL
expressing	NULL
the	NULL
Y497F	NULL
mutant	NULL
failed	NULL
to	NULL
phosphorylate	NULL
IRS2	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
,	NULL
whereas	NULL
cells	NULL
expressing	NULL
the	NULL
WT	NULL
hIL-4R	NULL
a-chain	NULL
showed	NULL
quite	NULL
clear	NULL
phosphorylation	NULL
of	NULL
this	NULL
adaptor	NULL
.	NULL

Whether	NULL
the	NULL
PTBD	NULL
proteins	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
controlling	NULL
resistance	NULL
to	NULL
apoptosis	NULL
early	NULL
in	NULL
their	NULL
response	NULL
to	NULL
IL-4	NULL
is	NULL
an	NULL
interesting	NULL
possibil-ity	NULL
.	NULL

However	NULL
,	NULL
this	NULL
was	NULL
quite	NULL
difficult	NULL
to	NULL
test	NULL
in	NULL
the	NULL
retroviral	NULL
infection	NULL
system	NULL
,	NULL
because	NULL
truly	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
resistant	NULL
to	NULL
infection	NULL
(	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
successful	NULL
T	NULL
cell	NULL
infection	NULL
in	NULL
the	NULL
retroviral	NULL
system	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
tend	NULL
to	NULL
survive	NULL
quite	NULL
well	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
IL-4	NULL
sparing	NULL
of	NULL
T	NULL
cell	NULL
apoptosis	NULL
before	NULL
new	NULL
gene	NULL
activation	NULL
is	NULL
dependent	NULL
on	NULL
PTBD	NULL
proteins	NULL
,	NULL
but	NULL
determining	NULL
whether	NULL
this	NULL
is	NULL
true	NULL
will	NULL
require	NULL
additional	NULL
study	NULL
.	NULL

Other	NULL
potential	NULL
IL-4R-mediated	NULL
functions	NULL
,	NULL
such	NULL
as	NULL
cell	NULL
adhesion	NULL
,	NULL
cell	NULL
mi-gration	NULL
,	NULL
and	NULL
cell-cell	NULL
interactions	NULL
,	NULL
will	NULL
need	NULL
to	NULL
be	NULL
studied	NULL
for	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
PTBD	NULL
proteins	NULL
.	NULL

The	NULL
Stat6-dependent	NULL
induction	NULL
and	NULL
activation	NULL
of	NULL
Gata3	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
is	NULL
well	NULL
established	NULL
as	NULL
playing	NULL
a	NULL
central	NULL
role	NULL
in	NULL
Th2	NULL
differentiation	NULL
(	NULL
31-34	NULL
,	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Because	NULL
activated	NULL
Stat6	NULL
is	NULL
sufficient	NULL
to	NULL
mediate	NULL
both	NULL
IL-4-driven	NULL
Th2	NULL
differentiation	NULL
and	NULL
cell	NULL
expansion	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
Gata3	NULL
also	NULL
contributes	NULL
to	NULL
IL-4-driven	NULL
cell	NULL
proliferation	NULL
or	NULL
whether	NULL
this	NULL
Stat6	NULL
effect	NULL
is	NULL
Gata3	NULL
independent	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
K.	NULL
M.	NULL
Murphy	NULL
for	NULL
providing	NULL
GFP-RV	NULL
,	NULL
U.	NULL
Schindler	NULL
for	NULL
providing	NULL
pcDNA3-Stat6VT	NULL
,	NULL
G.	NULL
Nolan	NULL
for	NULL
providing	NULL
Phoenix-Eco	NULL
packaging	NULL
cell	NULL
line	NULL
.	NULL

and	NULL
C.	NULL
Eigsti	NULL
for	NULL
excellent	NULL
cell	NULL
sorting	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1994	NULL
.	NULL

Acquisition	NULL
of	NULL
lymphokine-producing	NULL
phenotype	NULL
by	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:635	NULL
.	NULL

2	NULL
.	NULL

Nelms	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
J.	NULL
Zamorano	NULL
,	NULL
J.	NULL
J.	NULL
Ryan	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
IL-4	NULL
receptor	NULL
:	NULL
signaling	NULL
mechanisms	NULL
and	NULL
biologic	NULL
functions	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

17:701	NULL
.	NULL

3	NULL
.	NULL

Ohara	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1987	NULL
.	NULL

Receptors	NULL
for	NULL
B-cell	NULL
stimulatory	NULL
factor-1	NULL
expressed	NULL
on	NULL
cells	NULL
of	NULL
haematopoictic	NULL
lineage	NULL
.	NULL

Nature	NULL
325:537	NULL
.	NULL

4	NULL
.	NULL

Sugamura	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Asao	NULL
,	NULL
M.	NULL
Kondo	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
K.	NULL
Ohbo	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
T.	NULL
Takeshita	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
interleukin-2	NULL
receptor	NULL
-y	NULL
chain	NULL
:	NULL
its	NULL
role	NULL
in	NULL
the	NULL
multiple	NULL
cytokine	NULL
receptor	NULL
complexes	NULL
and	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
XSCID	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:179	NULL
.	NULL

5	NULL
.	NULL

Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
Miura	NULL
,	NULL
K.	NULL
S.	NULL
Lai	NULL
,	NULL
C.	NULL
Cwik	NULL
,	NULL
E.	NULL
T.	NULL
Liu	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Ihle	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
Jak-3	NULL
Janus	NULL
kinase	NULL
in	NULL
signalling	NULL
by	NULL
inter-leukins	NULL
2	NULL
and	NULL
4	NULL
in	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

Nature	NULL
370:153	NULL
.	NULL

6	NULL
.	NULL

Yin	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
L.	NULL
Tsang	NULL
,	NULL
and	NULL
Y.	NULL
C.	NULL
Yang	NULL
.	NULL

1994	NULL
.	NULL

JAK1	NULL
kinase	NULL
forms	NULL
complexes	NULL
with	NULL
interleukin-4	NULL
receptor	NULL
and	NULL
4PS/insulin	NULL
receptor	NULL
substrate-l-like	NULL
protein	NULL
and	NULL
is	NULL
activated	NULL
by	NULL
interleukin-4	NULL
and	NULL
interleukin-9	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:26614	NULL
.	NULL

7	NULL
.	NULL

Chen	NULL
,	NULL
X.	NULL
H.	NULL
,	NULL
B.	NULL
K.	NULL
R.	NULL
Patel	NULL
,	NULL
L.	NULL
M.	NULL
Wang	NULL
,	NULL
M.	NULL
Frankel	NULL
,	NULL
N.	NULL
Ellmore	NULL
,	NULL
R.	NULL
A.	NULL
Flavell	NULL
,	NULL
W.	NULL
J.	NULL
LaRochelle	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Pierce	NULL
.	NULL

1997	NULL
.	NULL

Jak1	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
interleukin-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
insulin	NULL
receptor	NULL
substrate	NULL
and	NULL
state	NULL
signaling	NULL
molecules	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:6556	NULL
.	NULL

8	NULL
.	NULL

Wang	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
G.	NULL
E.	NULL
Lienhard	NULL
,	NULL
S.	NULL
Pacini	NULL
,	NULL
J.	NULL
S.	NULL
Gutkind	NULL
,	NULL
M.	NULL
G.	NULL
Myers	NULL
,	NULL
Jr	NULL
,	NULL
X.	NULL
J	NULL
.	NULL

Sun	NULL
,	NULL
M.	NULL
F.	NULL
White	NULL
,	NULL
S.	NULL
A.	NULL
Aaronson	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Common	NULL
elements	NULL
in	NULL
interleukin	NULL
4	NULL
and	NULL
insulin	NULL
signaling	NULL
pathways	NULL
in	NULL
factor-dependent	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:4032	NULL
.	NULL

9	NULL
.	NULL

Wang	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
M.	NULL
G.	NULL
Myers	NULL
,	NULL
Jr.	NULL
,	NULL
X.	NULL
J	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
A.	NULL
Aaronson	NULL
,	NULL
M.	NULL
F.	NULL
White	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Pierce	NULL
.	NULL

1993	NULL
.	NULL

IRS-1	NULL
:	NULL
essential	NULL
for	NULL
insulin-	NULL
and	NULL
IL-4-stimulated	NULL
mitogenesis	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Science	NULL
261:1591	NULL
.	NULL

10	NULL
.	NULL

Sun	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
L.	NULL
M.	NULL
Wang	NULL
,	NULL
Y.	NULL
Zhang	NULL
,	NULL
L.	NULL
Yenush	NULL
,	NULL
M.	NULL
G.	NULL
Jr.	NULL
Myers	NULL
,	NULL
E.	NULL
Glasheen	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
White	NULL
.	NULL

1995	NULL
.	NULL

Role	NULL
of	NULL
IRS-2	NULL
in	NULL
insulin	NULL
and	NULL
cytokine	NULL
signalling	NULL
.	NULL

Nature	NULL
377:173	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

Wery	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Letourneur	NULL
,	NULL
J.	NULL
Bertoglio	NULL
,	NULL
and	NULL
J.	NULL
Pierre	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-4	NULL
induces	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
and	NULL
phosphorylation	NULL
of	NULL
she	NULL
in	NULL
human	NULL
keratinocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8529	NULL
.	NULL

Nelms	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
L.	NULL
Snow	NULL
,	NULL
J.	NULL
Hu-Li	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1998	NULL
.	NULL

FRIP	NULL
,	NULL
a	NULL
hematopoietic	NULL
cell-specific	NULL
rasGAP-interacting	NULL
protein	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

Immunity	NULL
9:13	NULL
.	NULL

Carpino	NULL
,	NULL
N.	NULL
,	NULL
D.	NULL
Wisniewski	NULL
,	NULL
A	NULL
.	NULL

Strife	NULL
,	NULL
D.	NULL
Marshak	NULL
,	NULL
R.	NULL
Kobayashi	NULL
,	NULL
B.	NULL
Stillman	NULL
,	NULL
and	NULL
B.	NULL
Clarkson	NULL
.	NULL

1997.	NULL
p62	NULL
``	NULL
:	NULL
a	NULL
constitutively	NULL
tyrosine-phosphorylated	NULL
,	NULL
GAP-associated	NULL
protein	NULL
in	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
progenitor	NULL
cells	NULL
.	NULL

Cell	NULL
88	NULL
:	NULL
197	NULL
.	NULL

Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1997	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
Abl-	NULL
and	NULL
rasGAP-associated	NULL
62	NULL
kDa	NULL
protein	NULL
as	NULL
a	NULL
docking	NULL
protein	NULL
,	NULL
Dok	NULL
.	NULL

Cell	NULL
88:205	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
T.	NULL
C.	NULL
Ho	NULL
,	NULL
M.	NULL
Brasseur	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
:	NULL
IL-4	NULL
Stat	NULL
.	NULL

Science	NULL
265:1701	NULL
.	NULL

Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
K.	NULL
Shimoda	NULL
,	NULL
W.	NULL
Thierfelder	NULL
,	NULL
C.	NULL
Fischer	NULL
,	NULL
A.	NULL
Kim	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
J.	NULL
L.	NULL
Cleveland	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
of	NULL
murine	NULL
Stat6	NULL
and	NULL
human	NULL
Stat6	NULL
,	NULL
Stat	NULL
proteins	NULL
that	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
IL-3	NULL
but	NULL
are	NULL
not	NULL
required	NULL
for	NULL
mitogenesis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3336	NULL
.	NULL

Ryan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
L.	NULL
J.	NULL
McReynolds	NULL
,	NULL
H.	NULL
Huang	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1998	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
mobile	NULL
Stat6	NULL
activation	NULL
motif	NULL
in	NULL
the	NULL
human	NULL
IL-4	NULL
receptor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:1811	NULL
.	NULL

Ryan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
L.	NULL
J.	NULL
McReynolds	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
L.	NULL
H.	NULL
Wang	NULL
,	NULL
E.	NULL
Garfein	NULL
,	NULL
P.	NULL
Rothman	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1996	NULL
.	NULL

Growth	NULL
and	NULL
gene	NULL
expression	NULL
are	NULL
predominantly	NULL
controlled	NULL
by	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
receptor	NULL
.	NULL

Immunity	NULL
4:123	NULL
.	NULL

Pemis	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Witthuhn	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
E.	NULL
Garfein	NULL
,	NULL
J.	NULL
N.	NULL
Thle	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
4	NULL
signals	NULL
through	NULL
two	NULL
related	NULL
pathways	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7971	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
M.	NULL
,	NULL
White	NULL
,	NULL
L.	NULL
M.	NULL
Wang	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
IL-4	NULL
receptor	NULL
region	NULL
containing	NULL
an	NULL
insulin	NULL
receptor	NULL
motif	NULL
is	NULL
important	NULL
for	NULL
IL-4-mediated	NULL
IRS-1	NULL
phosphorylation	NULL
and	NULL
cell	NULL
growth	NULL
.	NULL

Cell	NULL
76:811	NULL
.	NULL

Zamorano	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Y.	NULL
Wang	NULL
,	NULL
L.	NULL
M.	NULL
Wang	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Keegan	NULL
.	NULL

1996	NULL
.	NULL

IL-4	NULL
protects	NULL
cells	NULL
from	NULL
apoptosis	NULL
via	NULL
the	NULL
insulin	NULL
receptor	NULL
substrate	NULL
pathway	NULL
and	NULL
a	NULL
second	NULL
independent	NULL
signaling	NULL
pathway	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:4926	NULL
.	NULL

Zamorano	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Keegan	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
apoptosis	NULL
by	NULL
tyrosine-containing	NULL
domains	NULL
of	NULL
IL-4Ra	NULL
:	NULL
Y497	NULL
and	NULL
Y713	NULL
,	NULL
but	NULL
not	NULL
the	NULL
STAT6-docking	NULL
tyrosines	NULL
,	NULL
signal	NULL
protection	NULL
from	NULL
apoptosis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:859	NULL
.	NULL

Defrance	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
P.	NULL
Aubry	NULL
,	NULL
F.	NULL
Rousset	NULL
,	NULL
B.	NULL
Vanbervliet	NULL
,	NULL
J.	NULL
Y.	NULL
Bonnefoy	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
Y.	NULL
Takebe	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
et	NULL
al.1987	NULL
.	NULL

Human	NULL
recombinant	NULL
interleukin	NULL
4	NULL
induces	NULL
Fee	NULL
receptors	NULL
(	NULL
CD23	NULL
)	NULL
on	NULL
normal	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:1459	NULL
.	NULL

Mikita	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Kurama	NULL
,	NULL
and	NULL
U.	NULL
Schindler	NULL
.	NULL

1998	NULL
.	NULL

Synergistic	NULL
activation	NULL
of	NULL
the	NULL
germline	NULL
epsilon	NULL
promoter	NULL
mediated	NULL
by	NULL
Stat6é	NULL
and	NULL
J.	NULL
Immunol	NULL
.	NULL

161	NULL
:	NULL
1822	NULL
.	NULL

Shen	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
J.	NULL
Stavnezer	NULL
.	NULL

1998	NULL
.	NULL

Interaction	NULL
of	NULL
stat6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
direct	NULL
association	NULL
and	NULL
synergistic	NULL
activation	NULL
of	NULL
interleukin-4-induced	NULL
transcription	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:3395	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

7281	NULL
Linchan	NULL
,	NULL
L.	NULL
A.	NULL
W.	NULL
D.	NULL
Warren	NULL
,	NULL
P.	NULL
A.	NULL
Thompson	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
M.	NULL
T.	NULL
Berton	NULL
.	NULL

1998	NULL
.	NULL

STAT6	NULL
is	NULL
required	NULL
for	NULL
IL-4-induced	NULL
germline	NULL
Ig	NULL
gene	NULL
transcription	NULL
and	NULL
switch	NULL
recombination	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:302	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
N.	NULL
C.	NULL
Reich	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-4-induced	NULL
STAT6	NULL
recognizes	NULL
and	NULL
activates	NULL
a	NULL
target	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:25555	NULL
.	NULL

Qian	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1997	NULL
.	NULL

T	NULL
cells	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

9:205	NULL
.	NULL

Avni	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

2000	NULL
.	NULL

T	NULL
cell	NULL
differentiation	NULL
:	NULL
a	NULL
mechanistic	NULL
view	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

12:654	NULL
.	NULL

O'Gara	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

2000	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
of	NULL
T	NULL
helper	NULL
1	NULL
and	NULL
T	NULL
helper	NULL
2	NULL
cell	NULL
differentiation	NULL
.	NULL

Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

10:542	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
van	NULL
Deursen	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
S.	NULL
R.	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
C.	NULL
Chu	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
Vignali	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
380:630	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
W.	NULL
Shi	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
M.	NULL
Minami	NULL
,	NULL
S.	NULL
Kashiwamura	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1996	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4	NULL
signalling	NULL
.	NULL

Nature	NULL
380:627	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
S.	NULL
T.	NULL
Smiley	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

Stat6	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
for	NULL
the	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

Immunity	NULL
4:313	NULL
.	NULL

Ouyang	NULL
,	NULL
W.	NULL
,	NULL
S.	NULL
H.	NULL
Ranganath	NULL
,	NULL
K.	NULL
Weindel	NULL
,	NULL
D.	NULL
Bhattacharya	NULL
,	NULL
T.	NULL
L.	NULL
Murphy	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1998	NULL
.	NULL

Inhibition	NULL
of	NULL
Th1	NULL
development	NULL
mediated	NULL
by	NULL
GATA-3	NULL
through	NULL
an	NULL
IL-4-independent	NULL
mechanism	NULL
.	NULL

Immunity	NULL
9:745	NULL
.	NULL

Daniel	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Salvekar	NULL
,	NULL
and	NULL
U.	NULL
Schindler	NULL
.	NULL

2000	NULL
.	NULL

A	NULL
gain-of-function	NULL
mutation	NULL
in	NULL
STAT6	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275:14255	NULL
.	NULL

Zheng	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
89:587	NULL
.	NULL

Ouyang	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
M.	NULL
Lohning	NULL
,	NULL
Z.	NULL
G.	NULL
Gao	NULL
,	NULL
M.	NULL
Assenmacher	NULL
,	NULL
S.	NULL
Ranganath	NULL
,	NULL
A.	NULL
Radbruch	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

2000	NULL
.	NULL

Stat6-independent	NULL
GATA-3	NULL
autoactiva-tion	NULL
directs	NULL
IL-4-independent	NULL
Th2	NULL
development	NULL
and	NULL
commitment	NULL
.	NULL

Immunity	NULL
12	NULL
;	NULL
27	NULL
.	NULL

Ben-Sasson	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
K.	NULL
Makedonski	NULL
,	NULL
J.	NULL
Hu-Li	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

2000	NULL
.	NULL

Survival	NULL
and	NULL
cytokine	NULL
polarization	NULL
of	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
is	NULL
largely	NULL
dependent	NULL
on	NULL
exogenous	NULL
cytokines	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30:1308	NULL
.	NULL

Zhu	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Huang	NULL
,	NULL
L.	NULL
Guo	NULL
,	NULL
T.	NULL
Stonehouse	NULL
,	NULL
C.	NULL
J.	NULL
Watson	NULL
,	NULL
J.	NULL
Hu-Li	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

2000	NULL
.	NULL

Transient	NULL
inhibition	NULL
of	NULL
interleukin	NULL
4	NULL
signaling	NULL
by	NULL
T	NULL
cell	NULL
receptor	NULL
ligation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

192:1125	NULL
.	NULL

Dent	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
J.	NULL
Hu-Li	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Staudt	NULL
.	NULL

1998	NULL
.	NULL

T	NULL
helper	NULL
type	NULL
2	NULL
inflammatory	NULL
disease	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
interleukin	NULL
4	NULL
and	NULL
transcription	NULL
factor	NULL
STAT6	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:13823	NULL
.	NULL

Jankovic	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
C.	NULL
Kullberg	NULL
,	NULL
N.	NULL
Noben-Trauth	NULL
,	NULL
P.	NULL
Caspar	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
A.	NULL
Sher	NULL
.	NULL

2000	NULL
.	NULL

Single	NULL
cell	NULL
analysis	NULL
reveals	NULL
that	NULL
IL-4	NULL
receptor/Stat6	NULL
signaling	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
in	NULL
vivo	NULL
or	NULL
in	NULL
vitro	NULL
development	NULL
of	NULL
CD4	NULL
*	NULL
lymphocytes	NULL
with	NULL
a	NULL
Th2	NULL
cytokine	NULL
profile	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

164:3047	NULL
.	NULL

Kurata	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
J.	NULL
Lee	NULL
,	NULL
A.	NULL
O'Garra	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1999	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
activated	NULL
Stat6	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
Th2-specific	NULL
cytokines	NULL
and	NULL
transcription	NULL
factors	NULL
in	NULL
developing	NULL
Th1	NULL
cells	NULL
.	NULL

Immunity	NULL
11:677	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

